Live feed
Filing
SC 13D
SC 13D0001753926-24-000393·Pelthos Therapeutics Inc.
Schedule 13D ownership disclosure
CHROMOCELL THERAPEUTICS CORP
Security class unavailable · CUSIP: 171126105
Event date: 2024-02-15
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001753926-24-000393
- Form type
- SC 13D
- Filer
- Pelthos Therapeutics Inc.
- CIK
- CIK 1919246
- Filed
- Feb 26, 2024
- Reporting period
- Feb 15, 2024
- Description
- Schedule 13D beneficial ownership